Summary
- Current Price
- As of today, INO price is $1.09, up +21.10% on
- Current Price All-Time High
- INO price is currently -99.95% below its historical high of $2,352.00 set on
- Market Cap
- INO current market cap is $113M, up +89.34% over the past 365 days
- Revenue
- INO current annual revenue is $65.30K, down -70.02% year-over-year
- Next Earnings
- As of today, the next earnings release for INO has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Inovio Pharmaceuticals, Inc. |
| Ticker | NASDAQ: INO |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | inovio.com |
| Employees | 134 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $1.09 | ||
| Price, 1D Change | +21.10% | |
| $113M | ||
| - | ||
| - | ||
| 0.62 | ||
| $65.30K | ||
| Revenue, 1Y Change | -70.02% | |
| -$1.81 | ||
| EPS, 1Y Change | +54.12% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:12 | |
| Next Split | N/A | N/A |
| Last Ticker Change | GEB | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$1.81 | ||
| EPS Estimate | -$1.14 | N/A |
| EPS Est. Change | +37.08% | N/A |
| $65.30K | ||
| Revenue Estimate | $666.67K | N/A |
| Revenue Est. Change | +920.93% | N/A |
| $1.09 | ||
| Price Target | $2.50 | - |
| Price Tgt. Change | +129.36% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$4.21 | -$3.95 | +6.20% | |
| -$2.34 | -$1.81 | +22.49% | |
| -$1.14 | N/A | +37.08% | |
| -$0.46 | N/A | +74.89% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $125.33K | $217.80K | +73.78% | |
| $88.33K | $65.30K | -26.07% | |
| $666.67K | N/A | +920.93% | |
| $51.31M | N/A | +78,468.65% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| -32.72% | ||
| -80.25% | ||
| +89.34% | ||
| -8.67% | ||
| -70.02% | ||
| -99.36% | ||
| +54.12% | ||
| +87.13% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $1.09 | ||
| $1.50 | ||
| $1.03 | ||
| $1.48 | ||
| $1.00 | ||
| -$0.06 | ||
| 0.62 | ||
| $0.09 | ||
| 62.50 | ||
| 134.49% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $65.30K | ||
| -$1.81 | ||
| -$2.92M | ||
| -4,477.03% | ||
| -$86.82M | ||
| -132.96% | ||
| -$84.95M | ||
| -130.09% | ||
| -$83.83M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.39 | ||
| 1.40 | ||
| 1.40 | ||
| - | ||
| - | ||
| -35.77 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 18.56 | ||
| -1.04 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $24.10M | ||
| $58.51M | ||
| $75.68M | ||
| $61.12M | ||
| $51.59M | ||
| $43.67M | ||
| $9.37M | ||
| $2.82M | ||
| $2.62M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $85.01M | ||
| $83.90M | ||
| $2.99M | ||
| $0.00 | ||
| $2.99M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$88.63M | ||
| $14.04M | ||
| $53.05M | ||
| $285.70K | ||
| -$88.92M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Piper Sandler | → | |
| HC Wainwright & Co. | → | |
| Piper Sandler | → | |
| HC Wainwright & Co. | → | |
| Piper Sandler | ||
| RBC Capital | → | |
| Oppenheimer | → | |
| RBC Capital | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with INO
FAQ
- What is the ticker symbol for Inovio Pharmaceuticals, Inc.?
- The ticker symbol for Inovio Pharmaceuticals, Inc. is NASDAQ:INO
- Does Inovio Pharmaceuticals, Inc. pay dividends?
- No, Inovio Pharmaceuticals, Inc. does not pay dividends
- What sector is Inovio Pharmaceuticals, Inc. in?
- Inovio Pharmaceuticals, Inc. is in the Healthcare sector
- What industry is Inovio Pharmaceuticals, Inc. in?
- Inovio Pharmaceuticals, Inc. is in the Biotechnology industry
- What country is Inovio Pharmaceuticals, Inc. based in?
- Inovio Pharmaceuticals, Inc. is headquartered in United States
- When did Inovio Pharmaceuticals, Inc. go public?
- Inovio Pharmaceuticals, Inc. initial public offering (IPO) was on December 8, 1998
- Is Inovio Pharmaceuticals, Inc. in the S&P 500?
- No, Inovio Pharmaceuticals, Inc. is not included in the S&P 500 index
- Is Inovio Pharmaceuticals, Inc. in the NASDAQ 100?
- No, Inovio Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
- Is Inovio Pharmaceuticals, Inc. in the Dow Jones?
- No, Inovio Pharmaceuticals, Inc. is not included in the Dow Jones index
- When was Inovio Pharmaceuticals, Inc. last earnings report?
- Inovio Pharmaceuticals, Inc.'s most recent earnings report was on August 12, 2026
- When does Inovio Pharmaceuticals, Inc. report earnings?
- The date for Inovio Pharmaceuticals, Inc.'s next earnings report has not been announced yet
Data Sources & References
- INO Official Website www.inovio.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1055726/000105572626000008/0001055726-26-000008-index.htm
- INO Profile on Yahoo Finance finance.yahoo.com/quote/INO
- INO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ino